Avoro Capital Advisors LLC Krystal Biotech, Inc. Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,660,000 shares of KRYS stock, worth $382 Million. This represents 6.67% of its overall portfolio holdings.
Number of Shares
2,660,000
Previous 2,731,000
2.6%
Holding current value
$382 Million
Previous $492 Million
25.74%
% of portfolio
6.67%
Previous 7.97%
Shares
14 transactions
Others Institutions Holding KRYS
# of Institutions
310Shares Held
24.7MCall Options Held
419KPut Options Held
489K-
Black Rock Inc. New York, NY3.95MShares$567 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$405 Million0.01% of portfolio
-
State Street Corp Boston, MA1.36MShares$195 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$135 Million0.02% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT923KShares$133 Million9.83% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.69B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...